

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.95059932 |
| 2 | ensheathment of neurons (GO:0007272) | 6.64485227 |
| 3 | axon ensheathment (GO:0008366) | 6.64485227 |
| 4 | myelination (GO:0042552) | 6.52527312 |
| 5 | creatine metabolic process (GO:0006600) | 6.02935939 |
| 6 | response to methylmercury (GO:0051597) | 5.97807732 |
| 7 | myelin maintenance (GO:0043217) | 5.60323812 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.29801212 |
| 9 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.82143684 |
| 10 | cholesterol biosynthetic process (GO:0006695) | 4.62597814 |
| 11 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.58676551 |
| 12 | oligodendrocyte differentiation (GO:0048709) | 4.41641313 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.41325586 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.41325586 |
| 15 | amyloid precursor protein metabolic process (GO:0042982) | 4.36321536 |
| 16 | barbed-end actin filament capping (GO:0051016) | 4.35688825 |
| 17 | establishment of mitochondrion localization (GO:0051654) | 4.34376440 |
| 18 | heme transport (GO:0015886) | 4.31081733 |
| 19 | negative regulation of protein localization to cell surface (GO:2000009) | 4.25495396 |
| 20 | response to lead ion (GO:0010288) | 4.15935453 |
| 21 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.08590240 |
| 22 | sterol biosynthetic process (GO:0016126) | 4.07527263 |
| 23 | protein maturation by protein folding (GO:0022417) | 3.99212251 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 3.95544873 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95544873 |
| 26 | substantia nigra development (GO:0021762) | 3.95442897 |
| 27 | iron coordination entity transport (GO:1901678) | 3.88905969 |
| 28 | GDP-mannose metabolic process (GO:0019673) | 3.88649085 |
| 29 | heme biosynthetic process (GO:0006783) | 3.82240341 |
| 30 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.79902192 |
| 31 | membrane tubulation (GO:0097320) | 3.77976569 |
| 32 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.76366581 |
| 33 | protein retention in ER lumen (GO:0006621) | 3.75989907 |
| 34 | regulation of collateral sprouting (GO:0048670) | 3.75861311 |
| 35 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.74815319 |
| 36 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.70457563 |
| 37 | very long-chain fatty acid metabolic process (GO:0000038) | 3.68979685 |
| 38 | Golgi transport vesicle coating (GO:0048200) | 3.68445957 |
| 39 | COPI coating of Golgi vesicle (GO:0048205) | 3.68445957 |
| 40 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.66336403 |
| 41 | regulation of lipoprotein metabolic process (GO:0050746) | 3.59685465 |
| 42 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.59182204 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.58234488 |
| 44 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.56532350 |
| 45 | import into cell (GO:0098657) | 3.55499115 |
| 46 | isoprenoid biosynthetic process (GO:0008299) | 3.55166353 |
| 47 | heme metabolic process (GO:0042168) | 3.53143281 |
| 48 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.52069621 |
| 49 | negative regulation of neurotransmitter transport (GO:0051589) | 3.51224102 |
| 50 | astrocyte development (GO:0014002) | 3.47758946 |
| 51 | acyl-CoA biosynthetic process (GO:0071616) | 3.47380097 |
| 52 | thioester biosynthetic process (GO:0035384) | 3.47380097 |
| 53 | GPI anchor biosynthetic process (GO:0006506) | 3.45301273 |
| 54 | amyloid precursor protein catabolic process (GO:0042987) | 3.38651180 |
| 55 | tetrapyrrole biosynthetic process (GO:0033014) | 3.37667802 |
| 56 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.37624919 |
| 57 | pyrimidine-containing compound salvage (GO:0008655) | 3.37451577 |
| 58 | pyrimidine nucleoside salvage (GO:0043097) | 3.37451577 |
| 59 | NIK/NF-kappaB signaling (GO:0038061) | 3.33180451 |
| 60 | response to redox state (GO:0051775) | 3.31277111 |
| 61 | glutathione biosynthetic process (GO:0006750) | 3.28403726 |
| 62 | amino sugar catabolic process (GO:0046348) | 3.28290254 |
| 63 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.27385678 |
| 64 | protein localization to endosome (GO:0036010) | 3.27287181 |
| 65 | glycosphingolipid catabolic process (GO:0046479) | 3.26806319 |
| 66 | porphyrin-containing compound metabolic process (GO:0006778) | 3.25015002 |
| 67 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22334168 |
| 68 | adhesion of symbiont to host cell (GO:0044650) | 3.22228667 |
| 69 | virion attachment to host cell (GO:0019062) | 3.22228667 |
| 70 | GPI anchor metabolic process (GO:0006505) | 3.21594581 |
| 71 | pinocytosis (GO:0006907) | 3.17779962 |
| 72 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.14029321 |
| 73 | apical protein localization (GO:0045176) | 3.13889559 |
| 74 | photoreceptor cell differentiation (GO:0046530) | 3.10895743 |
| 75 | eye photoreceptor cell differentiation (GO:0001754) | 3.10895743 |
| 76 | peptidyl-cysteine modification (GO:0018198) | 3.09242396 |
| 77 | cofactor catabolic process (GO:0051187) | 3.08561837 |
| 78 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.08261295 |
| 79 | response to peptidoglycan (GO:0032494) | 3.06591586 |
| 80 | glycerophospholipid catabolic process (GO:0046475) | 3.05288761 |
| 81 | L-serine metabolic process (GO:0006563) | 3.03418671 |
| 82 | protein palmitoylation (GO:0018345) | 3.00218328 |
| 83 | myelination in peripheral nervous system (GO:0022011) | 2.99208187 |
| 84 | peripheral nervous system axon ensheathment (GO:0032292) | 2.99208187 |
| 85 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.99082925 |
| 86 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.97861141 |
| 87 | neuron remodeling (GO:0016322) | 2.97448868 |
| 88 | skin morphogenesis (GO:0043589) | 2.97296011 |
| 89 | L-amino acid import (GO:0043092) | 2.96909113 |
| 90 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.95690701 |
| 91 | glycine transport (GO:0015816) | 2.94925754 |
| 92 | response to mercury ion (GO:0046689) | 2.93648004 |
| 93 | glycolipid catabolic process (GO:0019377) | 2.92390842 |
| 94 | asymmetric protein localization (GO:0008105) | 2.91163369 |
| 95 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.91130144 |
| 96 | pentose-phosphate shunt (GO:0006098) | 2.89642513 |
| 97 | adult walking behavior (GO:0007628) | 2.89516506 |
| 98 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.88996810 |
| 99 | response to lipoprotein particle (GO:0055094) | 2.88700928 |
| 100 | respiratory electron transport chain (GO:0022904) | 2.87905011 |
| 101 | fibril organization (GO:0097435) | 2.87701393 |
| 102 | extracellular fibril organization (GO:0043206) | 2.86371029 |
| 103 | nucleotide transmembrane transport (GO:1901679) | 2.85982168 |
| 104 | type B pancreatic cell proliferation (GO:0044342) | 2.85315561 |
| 105 | axon development (GO:0061564) | 2.85073275 |
| 106 | glycosylceramide metabolic process (GO:0006677) | 2.82310008 |
| 107 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.81386378 |
| 108 | electron transport chain (GO:0022900) | 2.79300999 |
| 109 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.77723389 |
| 110 | adhesion of symbiont to host (GO:0044406) | 2.77195827 |
| 111 | acyl-CoA metabolic process (GO:0006637) | 2.76202766 |
| 112 | thioester metabolic process (GO:0035383) | 2.76202766 |
| 113 | ATP synthesis coupled proton transport (GO:0015986) | 2.74663665 |
| 114 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.74663665 |
| 115 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.71160838 |
| 116 | UV protection (GO:0009650) | 2.71064960 |
| 117 | neutrophil activation involved in immune response (GO:0002283) | 2.70328419 |
| 118 | peptide biosynthetic process (GO:0043043) | 2.68947519 |
| 119 | cellular response to epinephrine stimulus (GO:0071872) | 2.67837725 |
| 120 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66036189 |
| 121 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.64787704 |
| 122 | mature B cell differentiation involved in immune response (GO:0002313) | 2.63320578 |
| 123 | cholesterol metabolic process (GO:0008203) | 2.63248642 |
| 124 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63070038 |
| 125 | glial cell development (GO:0021782) | 2.62389047 |
| 126 | enteric nervous system development (GO:0048484) | 2.62265525 |
| 127 | proteasome assembly (GO:0043248) | 2.61743598 |
| 128 | negative regulation of JUN kinase activity (GO:0043508) | 2.61611984 |
| 129 | aspartate family amino acid catabolic process (GO:0009068) | 2.60073935 |
| 130 | glucose catabolic process (GO:0006007) | 2.59975611 |
| 131 | chaperone-mediated protein transport (GO:0072321) | 2.57750387 |
| 132 | regulation of superoxide anion generation (GO:0032928) | 2.57258008 |
| 133 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.57199863 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.55706446 |
| 135 | magnesium ion transport (GO:0015693) | 2.55448985 |
| 136 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.55358033 |
| 137 | hyaluronan catabolic process (GO:0030214) | 2.54643674 |
| 138 | positive regulation of extracellular matrix organization (GO:1903055) | 2.52471586 |
| 139 | nucleotide salvage (GO:0043173) | 2.52403491 |
| 140 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.51741671 |
| 141 | cyclooxygenase pathway (GO:0019371) | 2.50563316 |
| 142 | prostaglandin biosynthetic process (GO:0001516) | 2.49384576 |
| 143 | prostanoid biosynthetic process (GO:0046457) | 2.49384576 |
| 144 | nucleoside salvage (GO:0043174) | 2.48073448 |
| 145 | mitotic nuclear envelope reassembly (GO:0007084) | 2.46554582 |
| 146 | nuclear envelope reassembly (GO:0031468) | 2.46554582 |
| 147 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.44057351 |
| 148 | cellular response to zinc ion (GO:0071294) | 2.44027877 |
| 149 | modulation by symbiont of host cellular process (GO:0044068) | 2.43647560 |
| 150 | regulation of extracellular matrix disassembly (GO:0010715) | 2.43244447 |
| 151 | regulation of defense response to virus by virus (GO:0050690) | 2.42346280 |
| 152 | cellular response to arsenic-containing substance (GO:0071243) | 2.41337145 |
| 153 | immunoglobulin mediated immune response (GO:0016064) | 2.40250614 |
| 154 | ceramide catabolic process (GO:0046514) | 2.39451087 |
| 155 | response to progesterone (GO:0032570) | 2.39296017 |
| 156 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.38156251 |
| 157 | pentose metabolic process (GO:0019321) | 2.37390214 |
| 158 | apoptotic cell clearance (GO:0043277) | 2.35835755 |
| 159 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.34346012 |
| 160 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.34068897 |
| 161 | regulation of mitochondrial membrane potential (GO:0051881) | 2.33659169 |
| 162 | NADPH regeneration (GO:0006740) | 2.33509435 |
| 163 | regulation of early endosome to late endosome transport (GO:2000641) | 2.32350869 |
| 164 | regulation of metalloenzyme activity (GO:0048552) | 2.32211183 |
| 165 | lipopolysaccharide metabolic process (GO:0008653) | 2.31010527 |
| 166 | response to thyroid hormone (GO:0097066) | 2.30819372 |
| 167 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.29995981 |
| 168 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.28156785 |
| 169 | membrane raft organization (GO:0031579) | 2.26868844 |
| 170 | type I interferon signaling pathway (GO:0060337) | 2.26689928 |
| 171 | cellular response to type I interferon (GO:0071357) | 2.26689928 |
| 172 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26094727 |
| 173 | modulation by virus of host process (GO:0019054) | 2.24347861 |
| 174 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.23542169 |
| 175 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.22186222 |
| 176 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.22186222 |
| 177 | myeloid dendritic cell differentiation (GO:0043011) | 2.20948754 |
| 178 | response to type I interferon (GO:0034340) | 2.20759600 |
| 179 | lipoxygenase pathway (GO:0019372) | 2.20480458 |
| 180 | virion assembly (GO:0019068) | 2.20377889 |
| 181 | regulation of necrotic cell death (GO:0010939) | 2.18825238 |
| 182 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.17944280 |
| 183 | keratan sulfate catabolic process (GO:0042340) | 2.17784415 |
| 184 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.17381028 |
| 185 | membrane lipid catabolic process (GO:0046466) | 2.16541525 |
| 186 | sphingolipid catabolic process (GO:0030149) | 2.16332073 |
| 187 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.16055928 |
| 188 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.15291067 |
| 189 | regulation of superoxide metabolic process (GO:0090322) | 2.15220631 |
| 190 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.14949537 |
| 191 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.14949537 |
| 192 | embryo implantation (GO:0007566) | 2.14274230 |
| 193 | axon ensheathment in central nervous system (GO:0032291) | 11.2000500 |
| 194 | central nervous system myelination (GO:0022010) | 11.2000500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.83888915 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.45079405 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.20314346 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.16384942 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.08064337 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.90662718 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.77794317 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.57258116 |
| 9 | GATA1_19941826_ChIP-Seq_K562_Human | 2.54758526 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44500766 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.40652892 |
| 12 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.21616583 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.15856094 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12414109 |
| 15 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.05134879 |
| 16 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.01539964 |
| 17 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00181721 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99001215 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94496750 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83314087 |
| 21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.78919438 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74006510 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73305798 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.68952678 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68408405 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.68049174 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67285974 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65946789 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65508991 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.63708667 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62617679 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60712920 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60514235 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58289768 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56649480 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56631936 |
| 37 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.56324574 |
| 38 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54578692 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54302826 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52798863 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52588910 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52136086 |
| 43 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51001522 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50530371 |
| 45 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.48739058 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48567168 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48047768 |
| 48 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.46244763 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44672391 |
| 50 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.43580716 |
| 51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43364366 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42941739 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42219502 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41613973 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41012320 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.40851485 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40520617 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40443482 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39636276 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.39620413 |
| 61 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.39254030 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37866473 |
| 63 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37857197 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37847008 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34890368 |
| 66 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32924120 |
| 67 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32900475 |
| 68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.32691993 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.32404308 |
| 70 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31400688 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.30766942 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29743261 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29538425 |
| 74 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.28797159 |
| 75 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.28797159 |
| 76 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28624860 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28034801 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27721332 |
| 79 | MYC_22102868_ChIP-Seq_BL_Human | 1.26510320 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26405200 |
| 81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.26245490 |
| 82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26044457 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25454589 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.24917447 |
| 85 | * MAF_26560356_Chip-Seq_TH2_Human | 1.23938802 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23081623 |
| 87 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.22759821 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22752241 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21894638 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.21775933 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21225338 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21166187 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20332384 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19794493 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18762469 |
| 96 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18493789 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18473331 |
| 98 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17787724 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17470969 |
| 100 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.17360425 |
| 101 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16847611 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16205476 |
| 103 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16107372 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15706404 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15495461 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15237279 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14923387 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13991515 |
| 109 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13889319 |
| 110 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13662038 |
| 111 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13578584 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13319815 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13303061 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13010329 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12840407 |
| 116 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.12018996 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11761721 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11350217 |
| 119 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.10444793 |
| 120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10408013 |
| 121 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10107499 |
| 122 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09660553 |
| 123 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09430869 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08272651 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08120760 |
| 126 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07780552 |
| 127 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07229148 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06955024 |
| 129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06580689 |
| 130 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06508564 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06431809 |
| 132 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.05955280 |
| 133 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05931320 |
| 134 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05828712 |
| 135 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05583698 |
| 136 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05289770 |
| 137 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05202309 |
| 138 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03889483 |
| 139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03705105 |
| 140 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03585886 |
| 141 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03484098 |
| 142 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02952196 |
| 143 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02782599 |
| 144 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02219515 |
| 145 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01784872 |
| 146 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01359768 |
| 147 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01237100 |
| 148 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01127813 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00953380 |
| 150 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00745693 |
| 151 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00688873 |
| 152 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00375972 |
| 153 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00139032 |
| 154 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98263705 |
| 155 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97991511 |
| 156 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97824383 |
| 157 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96593657 |
| 158 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96181054 |
| 159 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95496927 |
| 160 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95239552 |
| 161 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94965082 |
| 162 | P68_20966046_ChIP-Seq_HELA_Human | 0.91441460 |
| 163 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90709966 |
| 164 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90533121 |
| 165 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88582464 |
| 166 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87797877 |
| 167 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86192704 |
| 168 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85358629 |
| 169 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85296567 |
| 170 | NCOR_22424771_ChIP-Seq_293T_Human | 0.84970219 |
| 171 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84960246 |
| 172 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83037521 |
| 173 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82120986 |
| 174 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79991478 |
| 175 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79277635 |
| 176 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79017996 |
| 177 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78776599 |
| 178 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78592383 |
| 179 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.78542636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.57633861 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 4.16135029 |
| 3 | MP0004147_increased_porphyrin_level | 3.98161381 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.29495368 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.94759410 |
| 6 | MP0003329_amyloid_beta_deposits | 2.94658526 |
| 7 | MP0001529_abnormal_vocalization | 2.88185868 |
| 8 | MP0005451_abnormal_body_composition | 2.74070935 |
| 9 | MP0003690_abnormal_glial_cell | 2.70325997 |
| 10 | MP0003436_decreased_susceptibility_to | 2.58516017 |
| 11 | MP0005083_abnormal_biliary_tract | 2.51148767 |
| 12 | MP0003880_abnormal_central_pattern | 2.44423429 |
| 13 | MP0004142_abnormal_muscle_tone | 2.44324046 |
| 14 | MP0005171_absent_coat_pigmentation | 2.41490234 |
| 15 | MP0009840_abnormal_foam_cell | 2.41408076 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.33389301 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.33193496 |
| 18 | MP0004270_analgesia | 2.30245876 |
| 19 | MP0001905_abnormal_dopamine_level | 2.29526944 |
| 20 | MP0000343_altered_response_to | 2.24120214 |
| 21 | MP0002272_abnormal_nervous_system | 2.19081495 |
| 22 | MP0003634_abnormal_glial_cell | 2.10156418 |
| 23 | MP0004510_myositis | 2.07357074 |
| 24 | MP0004885_abnormal_endolymph | 2.06971637 |
| 25 | MP0003303_peritoneal_inflammation | 2.06823144 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.03887066 |
| 27 | MP0003279_aneurysm | 2.03804214 |
| 28 | MP0001542_abnormal_bone_strength | 2.03656226 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 2.01685959 |
| 30 | MP0000858_altered_metastatic_potential | 2.01178719 |
| 31 | MP0000747_muscle_weakness | 2.00310184 |
| 32 | MP0003195_calcinosis | 1.95997636 |
| 33 | MP0000749_muscle_degeneration | 1.95259583 |
| 34 | MP0009785_altered_susceptibility_to | 1.88609987 |
| 35 | MP0004043_abnormal_pH_regulation | 1.82553355 |
| 36 | MP0002064_seizures | 1.79089551 |
| 37 | MP0002229_neurodegeneration | 1.77276350 |
| 38 | MP0004742_abnormal_vestibular_system | 1.75467135 |
| 39 | MP0005025_abnormal_response_to | 1.75328898 |
| 40 | MP0001486_abnormal_startle_reflex | 1.72078476 |
| 41 | MP0000604_amyloidosis | 1.71346249 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.70691476 |
| 43 | MP0002419_abnormal_innate_immunity | 1.67974707 |
| 44 | MP0008260_abnormal_autophagy | 1.66026762 |
| 45 | MP0001853_heart_inflammation | 1.64530106 |
| 46 | MP0004381_abnormal_hair_follicle | 1.63698814 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.62318038 |
| 48 | MP0005410_abnormal_fertilization | 1.61663480 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.57070163 |
| 50 | MP0004859_abnormal_synaptic_plasticity | 1.56030465 |
| 51 | MP0001958_emphysema | 1.55327538 |
| 52 | MP0001835_abnormal_antigen_presentation | 1.54645913 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.52045108 |
| 54 | MP0000685_abnormal_immune_system | 1.50918869 |
| 55 | MP0006054_spinal_hemorrhage | 1.48477446 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.43160897 |
| 57 | MP0005023_abnormal_wound_healing | 1.42728952 |
| 58 | MP0001485_abnormal_pinna_reflex | 1.42205616 |
| 59 | MP0005387_immune_system_phenotype | 1.39460257 |
| 60 | MP0001790_abnormal_immune_system | 1.39460257 |
| 61 | MP0005257_abnormal_intraocular_pressure | 1.39028184 |
| 62 | MP0005409_darkened_coat_color | 1.38226025 |
| 63 | MP0004858_abnormal_nervous_system | 1.37797059 |
| 64 | MP0002139_abnormal_hepatobiliary_system | 1.37733272 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.37304403 |
| 66 | MP0005165_increased_susceptibility_to | 1.37184135 |
| 67 | MP0003632_abnormal_nervous_system | 1.36253226 |
| 68 | MP0005330_cardiomyopathy | 1.35141252 |
| 69 | MP0004947_skin_inflammation | 1.34933010 |
| 70 | MP0003136_yellow_coat_color | 1.34722185 |
| 71 | MP0009764_decreased_sensitivity_to | 1.34707119 |
| 72 | MP0005166_decreased_susceptibility_to | 1.34380218 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.34215818 |
| 74 | MP0003724_increased_susceptibility_to | 1.33777125 |
| 75 | MP0005360_urolithiasis | 1.33277916 |
| 76 | MP0004036_abnormal_muscle_relaxation | 1.31882534 |
| 77 | MP0003448_altered_tumor_morphology | 1.31445622 |
| 78 | MP0001849_ear_inflammation | 1.28724898 |
| 79 | MP0009745_abnormal_behavioral_response | 1.27058911 |
| 80 | MP0003631_nervous_system_phenotype | 1.25364733 |
| 81 | MP0009046_muscle_twitch | 1.23273005 |
| 82 | MP0005058_abnormal_lysosome_morphology | 1.23021584 |
| 83 | MP0005671_abnormal_response_to | 1.22999681 |
| 84 | MP0008569_lethality_at_weaning | 1.21130060 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 1.20153731 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 1.19718498 |
| 87 | MP0000750_abnormal_muscle_regeneration | 1.19420586 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19161529 |
| 89 | MP0003300_gastrointestinal_ulcer | 1.17499897 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 1.17369205 |
| 91 | MP0008469_abnormal_protein_level | 1.17321086 |
| 92 | MP0001845_abnormal_inflammatory_respons | 1.16989737 |
| 93 | MP0002723_abnormal_immune_serum | 1.16814764 |
| 94 | MP0003633_abnormal_nervous_system | 1.15558442 |
| 95 | MP0002452_abnormal_antigen_presenting | 1.14999341 |
| 96 | MP0005390_skeleton_phenotype | 1.14415644 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.13657633 |
| 98 | MP0002998_abnormal_bone_remodeling | 1.13615713 |
| 99 | MP0009278_abnormal_bone_marrow | 1.11987364 |
| 100 | MP0000955_abnormal_spinal_cord | 1.10873690 |
| 101 | MP0008875_abnormal_xenobiotic_pharmacok | 1.08573256 |
| 102 | MP0005332_abnormal_amino_acid | 1.08049911 |
| 103 | MP0000751_myopathy | 1.07614056 |
| 104 | MP0000778_abnormal_nervous_system | 1.05870815 |
| 105 | MP0000681_abnormal_thyroid_gland | 1.05394364 |
| 106 | MP0002060_abnormal_skin_morphology | 1.05039688 |
| 107 | MP0003091_abnormal_cell_migration | 1.04518987 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 1.04331207 |
| 109 | MP0002066_abnormal_motor_capabilities/c | 1.04230133 |
| 110 | MP0003137_abnormal_impulse_conducting | 1.04018143 |
| 111 | MP0005423_abnormal_somatic_nervous | 1.03576787 |
| 112 | MP0004134_abnormal_chest_morphology | 1.02467480 |
| 113 | MP0002420_abnormal_adaptive_immunity | 1.02062174 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 1.01956682 |
| 115 | MP0001243_abnormal_dermal_layer | 1.01877093 |
| 116 | MP0001819_abnormal_immune_cell | 1.01628636 |
| 117 | MP0005623_abnormal_meninges_morphology | 1.01446553 |
| 118 | MP0005503_abnormal_tendon_morphology | 1.00838038 |
| 119 | MP0003186_abnormal_redox_activity | 1.00328861 |
| 120 | MP0001970_abnormal_pain_threshold | 0.99068774 |
| 121 | MP0000678_abnormal_parathyroid_gland | 0.97662946 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.97001236 |
| 123 | MP0005501_abnormal_skin_physiology | 0.96758334 |
| 124 | MP0010030_abnormal_orbit_morphology | 0.94723498 |
| 125 | MP0002882_abnormal_neuron_morphology | 0.94470288 |
| 126 | MP0005670_abnormal_white_adipose | 0.94429402 |
| 127 | MP0001348_abnormal_lacrimal_gland | 0.93905968 |
| 128 | MP0001346_abnormal_lacrimal_gland | 0.93073589 |
| 129 | MP0002796_impaired_skin_barrier | 0.92855895 |
| 130 | MP0004272_abnormal_basement_membrane | 0.91182649 |
| 131 | MP0002405_respiratory_system_inflammati | 0.89503455 |
| 132 | MP0005386_behavior/neurological_phenoty | 0.88748155 |
| 133 | MP0004924_abnormal_behavior | 0.88748155 |
| 134 | MP0000462_abnormal_digestive_system | 0.88371798 |
| 135 | MP0010234_abnormal_vibrissa_follicle | 0.87766918 |
| 136 | MP0005408_hypopigmentation | 0.87759814 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.86790277 |
| 138 | MP0005164_abnormal_response_to | 0.86717546 |
| 139 | MP0001800_abnormal_humoral_immune | 0.82684255 |
| 140 | MP0003075_altered_response_to | 0.82564084 |
| 141 | MP0000003_abnormal_adipose_tissue | 0.81968407 |
| 142 | MP0003191_abnormal_cellular_cholesterol | 0.81884067 |
| 143 | MP0004233_abnormal_muscle_weight | 0.81648167 |
| 144 | MP0002933_joint_inflammation | 0.81596236 |
| 145 | MP0003795_abnormal_bone_structure | 0.80984500 |
| 146 | MP0000490_abnormal_crypts_of | 0.80915262 |
| 147 | MP0000767_abnormal_smooth_muscle | 0.79941878 |
| 148 | MP0002837_dystrophic_cardiac_calcinosis | 0.79916196 |
| 149 | MP0008775_abnormal_heart_ventricle | 0.79872573 |
| 150 | MP0002822_catalepsy | 0.79484291 |
| 151 | MP0000733_abnormal_muscle_development | 0.79145359 |
| 152 | MP0002132_abnormal_respiratory_system | 0.78533210 |
| 153 | MP0005636_abnormal_mineral_homeostasis | 0.77861199 |
| 154 | MP0001666_abnormal_nutrient_absorption | 0.77848474 |
| 155 | MP0005666_abnormal_adipose_tissue | 0.76849696 |
| 156 | MP0005365_abnormal_bile_salt | 0.75516310 |
| 157 | MP0010678_abnormal_skin_adnexa | 0.75467533 |
| 158 | MP0006082_CNS_inflammation | 0.75157983 |
| 159 | MP0002332_abnormal_exercise_endurance | 0.74674687 |
| 160 | MP0002752_abnormal_somatic_nervous | 0.74628123 |
| 161 | MP0001440_abnormal_grooming_behavior | 0.74272926 |
| 162 | MP0005319_abnormal_enzyme/_coenzyme | 0.74181940 |
| 163 | MP0008874_decreased_physiological_sensi | 0.73759323 |
| 164 | MP0002067_abnormal_sensory_capabilities | 0.73565633 |
| 165 | MP0003763_abnormal_thymus_physiology | 0.73232317 |
| 166 | MP0002572_abnormal_emotion/affect_behav | 0.70042143 |
| 167 | MP0001963_abnormal_hearing_physiology | 0.68228547 |
| 168 | MP0002733_abnormal_thermal_nociception | 0.67390845 |
| 169 | MP0004087_abnormal_muscle_fiber | 0.67081270 |
| 170 | MP0001851_eye_inflammation | 0.66436124 |
| 171 | MP0002295_abnormal_pulmonary_circulatio | 0.65572413 |
| 172 | MP0000383_abnormal_hair_follicle | 0.65370179 |
| 173 | MP0001661_extended_life_span | 0.64747600 |
| 174 | MP0004085_abnormal_heartbeat | 0.64468372 |
| 175 | MP0005195_abnormal_posterior_eye | 0.62921372 |
| 176 | MP0000639_abnormal_adrenal_gland | 0.62745900 |
| 177 | MP0002063_abnormal_learning/memory/cond | 0.62443236 |
| 178 | MP0008438_abnormal_cutaneous_collagen | 0.59855785 |
| 179 | MP0000759_abnormal_skeletal_muscle | 0.57920339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.18213225 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.07046289 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.07046289 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.07046289 |
| 5 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.90684312 |
| 6 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.90684312 |
| 7 | Cerebral hypomyelination (HP:0006808) | 4.83854979 |
| 8 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.27884619 |
| 9 | Peripheral hypomyelination (HP:0007182) | 4.06215517 |
| 10 | Vertebral compression fractures (HP:0002953) | 4.05850100 |
| 11 | Sensory axonal neuropathy (HP:0003390) | 3.98543236 |
| 12 | Onion bulb formation (HP:0003383) | 3.84470231 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.72683699 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.71767107 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.70122816 |
| 16 | Leukodystrophy (HP:0002415) | 3.68882027 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.59894627 |
| 18 | Parakeratosis (HP:0001036) | 3.45390803 |
| 19 | Abnormality of the corticospinal tract (HP:0002492) | 3.44408729 |
| 20 | Spastic paraparesis (HP:0002313) | 3.42178884 |
| 21 | Distal lower limb muscle weakness (HP:0009053) | 3.38198875 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.29152461 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.29152461 |
| 24 | Abnormal auditory evoked potentials (HP:0006958) | 3.24073060 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 3.21254346 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.16905812 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.12679762 |
| 28 | Diaphragmatic weakness (HP:0009113) | 3.09809274 |
| 29 | Axonal loss (HP:0003447) | 3.09369228 |
| 30 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.08984264 |
| 31 | Myokymia (HP:0002411) | 3.08345961 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.05546782 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.05546782 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.05546782 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.02007842 |
| 36 | Spastic gait (HP:0002064) | 2.96269348 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.95196534 |
| 38 | Paralysis (HP:0003470) | 2.92718169 |
| 39 | Slow saccadic eye movements (HP:0000514) | 2.92531144 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.92337339 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92337339 |
| 42 | Progressive neurologic deterioration (HP:0002344) | 2.90993978 |
| 43 | Muscle fiber splitting (HP:0003555) | 2.90078478 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.89273301 |
| 45 | Petechiae (HP:0000967) | 2.89197891 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.84852025 |
| 47 | Cerebral hemorrhage (HP:0001342) | 2.84371482 |
| 48 | Distal upper limb amyotrophy (HP:0007149) | 2.83214440 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.83214440 |
| 50 | Loss of speech (HP:0002371) | 2.82742114 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.81410034 |
| 52 | Protrusio acetabuli (HP:0003179) | 2.80857330 |
| 53 | CNS hypomyelination (HP:0003429) | 2.80427654 |
| 54 | Intention tremor (HP:0002080) | 2.80247151 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.77954756 |
| 56 | Dysmetria (HP:0001310) | 2.74415154 |
| 57 | Retinal dysplasia (HP:0007973) | 2.73514431 |
| 58 | Achilles tendon contracture (HP:0001771) | 2.68721478 |
| 59 | Stridor (HP:0010307) | 2.66519231 |
| 60 | Acute encephalopathy (HP:0006846) | 2.63725449 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.62737025 |
| 62 | Cervical subluxation (HP:0003308) | 2.62579492 |
| 63 | Nuclear cataract (HP:0100018) | 2.61498958 |
| 64 | Hepatic necrosis (HP:0002605) | 2.59049341 |
| 65 | Ankle clonus (HP:0011448) | 2.58786888 |
| 66 | Acanthocytosis (HP:0001927) | 2.58015826 |
| 67 | Mitochondrial inheritance (HP:0001427) | 2.56967598 |
| 68 | Pheochromocytoma (HP:0002666) | 2.56732101 |
| 69 | 3-Methylglutaconic aciduria (HP:0003535) | 2.56147045 |
| 70 | Alacrima (HP:0000522) | 2.52915859 |
| 71 | Nasal polyposis (HP:0100582) | 2.50779697 |
| 72 | Poikilocytosis (HP:0004447) | 2.50357088 |
| 73 | Paraparesis (HP:0002385) | 2.50325148 |
| 74 | Cholelithiasis (HP:0001081) | 2.46389733 |
| 75 | Hand muscle atrophy (HP:0009130) | 2.45543863 |
| 76 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.45213256 |
| 77 | Abnormal gallbladder physiology (HP:0012438) | 2.44618097 |
| 78 | Cholecystitis (HP:0001082) | 2.44618097 |
| 79 | Ileus (HP:0002595) | 2.44204535 |
| 80 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43747246 |
| 81 | Hyperlipoproteinemia (HP:0010980) | 2.42748317 |
| 82 | Renal Fanconi syndrome (HP:0001994) | 2.41221216 |
| 83 | Rough bone trabeculation (HP:0100670) | 2.40586421 |
| 84 | Scanning speech (HP:0002168) | 2.40524188 |
| 85 | Joint stiffness (HP:0001387) | 2.40424718 |
| 86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.36930223 |
| 87 | Short nail (HP:0001799) | 2.36768540 |
| 88 | Foot dorsiflexor weakness (HP:0009027) | 2.36573125 |
| 89 | Methylmalonic acidemia (HP:0002912) | 2.35624551 |
| 90 | Ragged-red muscle fibers (HP:0003200) | 2.35488928 |
| 91 | Spastic tetraparesis (HP:0001285) | 2.34811169 |
| 92 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.33472237 |
| 93 | Reticulocytosis (HP:0001923) | 2.33380772 |
| 94 | Abnormality of the Achilles tendon (HP:0005109) | 2.33280145 |
| 95 | Neuroendocrine neoplasm (HP:0100634) | 2.32194049 |
| 96 | Recurrent abscess formation (HP:0002722) | 2.29256474 |
| 97 | Intrahepatic cholestasis (HP:0001406) | 2.28948364 |
| 98 | Hyporeflexia of lower limbs (HP:0002600) | 2.28237537 |
| 99 | Hyperbilirubinemia (HP:0002904) | 2.25862514 |
| 100 | Abnormality of the foot musculature (HP:0001436) | 2.23832184 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.22875922 |
| 102 | Hypokinesia (HP:0002375) | 2.22734569 |
| 103 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.22167104 |
| 104 | Recurrent bacterial skin infections (HP:0005406) | 2.21627951 |
| 105 | Eczematoid dermatitis (HP:0000976) | 2.21553286 |
| 106 | Amyloidosis (HP:0011034) | 2.20983224 |
| 107 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.20550702 |
| 108 | J-shaped sella turcica (HP:0002680) | 2.19475716 |
| 109 | Premature skin wrinkling (HP:0100678) | 2.17210030 |
| 110 | Choreoathetosis (HP:0001266) | 2.16749575 |
| 111 | Generalized amyotrophy (HP:0003700) | 2.15392810 |
| 112 | Increased connective tissue (HP:0009025) | 2.15221024 |
| 113 | Distal lower limb amyotrophy (HP:0008944) | 2.13818834 |
| 114 | Bulbar palsy (HP:0001283) | 2.11653631 |
| 115 | Poor speech (HP:0002465) | 2.11411738 |
| 116 | Increased CSF lactate (HP:0002490) | 2.07900270 |
| 117 | Hypertensive crisis (HP:0100735) | 2.07421036 |
| 118 | Progressive macrocephaly (HP:0004481) | 2.04502305 |
| 119 | Hypoplastic pelvis (HP:0008839) | 2.03871575 |
| 120 | Patchy hypopigmentation of hair (HP:0011365) | 2.03243166 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 2.02654603 |
| 122 | Cerebral edema (HP:0002181) | 2.02042697 |
| 123 | White forelock (HP:0002211) | 2.01633078 |
| 124 | Asymmetric septal hypertrophy (HP:0001670) | 2.01275801 |
| 125 | Xanthomatosis (HP:0000991) | 2.01157291 |
| 126 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00866358 |
| 127 | Elbow flexion contracture (HP:0002987) | 1.98832655 |
| 128 | Clumsiness (HP:0002312) | 1.98399593 |
| 129 | Insidious onset (HP:0003587) | 1.98296472 |
| 130 | Termporal pattern (HP:0011008) | 1.98296472 |
| 131 | Respiratory failure (HP:0002878) | 1.98036642 |
| 132 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98009244 |
| 133 | Gowers sign (HP:0003391) | 1.95908921 |
| 134 | Trismus (HP:0000211) | 1.95086648 |
| 135 | Increased serum ferritin (HP:0003281) | 1.95053203 |
| 136 | Peripheral demyelination (HP:0011096) | 1.94310870 |
| 137 | Obstructive lung disease (HP:0006536) | 1.93933747 |
| 138 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93933747 |
| 139 | Abnormal trabecular bone morphology (HP:0100671) | 1.91925900 |
| 140 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91880659 |
| 141 | Prolonged neonatal jaundice (HP:0006579) | 1.91056202 |
| 142 | Increased hepatocellular lipid droplets (HP:0006565) | 1.88783622 |
| 143 | Anteriorly placed anus (HP:0001545) | 1.88462568 |
| 144 | Infantile muscular hypotonia (HP:0008947) | 1.87770460 |
| 145 | Delusions (HP:0000746) | 1.87251338 |
| 146 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86185287 |
| 147 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.85264891 |
| 148 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.85264891 |
| 149 | Upper motor neuron abnormality (HP:0002127) | 1.84955043 |
| 150 | Hypertriglyceridemia (HP:0002155) | 1.84797034 |
| 151 | Ankle contracture (HP:0006466) | 1.83854602 |
| 152 | Decreased lacrimation (HP:0000633) | 1.83371186 |
| 153 | Increased muscle lipid content (HP:0009058) | 1.83128331 |
| 154 | Urinary incontinence (HP:0000020) | 1.82228081 |
| 155 | Ulnar deviation of the wrist (HP:0003049) | 1.81493019 |
| 156 | Abnormality of the gallbladder (HP:0005264) | 1.80758148 |
| 157 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79803712 |
| 158 | Glucose intolerance (HP:0000833) | 1.78804358 |
| 159 | Mediastinal lymphadenopathy (HP:0100721) | 1.78731455 |
| 160 | Cerebral aneurysm (HP:0004944) | 1.78366858 |
| 161 | Atrophic scars (HP:0001075) | 1.78016657 |
| 162 | Polygenic inheritance (HP:0010982) | 1.76547264 |
| 163 | Split foot (HP:0001839) | 1.76459128 |
| 164 | Purpura (HP:0000979) | 1.76049230 |
| 165 | Morphological abnormality of the inner ear (HP:0011390) | 1.74735467 |
| 166 | Spondylolisthesis (HP:0003302) | 1.73957478 |
| 167 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73935051 |
| 168 | Absent septum pellucidum (HP:0001331) | 1.73899276 |
| 169 | Hypoplasia of the iris (HP:0007676) | 1.72801539 |
| 170 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71200400 |
| 171 | Myopathic facies (HP:0002058) | 1.71067946 |
| 172 | Diminished motivation (HP:0000745) | 1.70267312 |
| 173 | Fragile skin (HP:0001030) | 1.70126651 |
| 174 | Atelectasis (HP:0100750) | 1.69984812 |
| 175 | Bone pain (HP:0002653) | 1.69885313 |
| 176 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.68067248 |
| 177 | Osteolytic defects of the hand bones (HP:0009699) | 1.68067248 |
| 178 | Acanthosis nigricans (HP:0000956) | 1.67503158 |
| 179 | Apathy (HP:0000741) | 1.67260836 |
| 180 | Neuronal loss in central nervous system (HP:0002529) | 1.67038813 |
| 181 | Myocardial infarction (HP:0001658) | 1.65859994 |
| 182 | Testicular atrophy (HP:0000029) | 1.65613289 |
| 183 | Abnormality of dentin (HP:0010299) | 1.65434159 |
| 184 | Spinal rigidity (HP:0003306) | 1.64813418 |
| 185 | Neoplasm of head and neck (HP:0012288) | 1.64681905 |
| 186 | Esophageal neoplasm (HP:0100751) | 1.64681905 |
| 187 | Dilatation of the ascending aorta (HP:0005111) | 1.64635195 |
| 188 | Cellulitis (HP:0100658) | 1.62637413 |
| 189 | Hyperparathyroidism (HP:0000843) | 1.62106519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.00363064 |
| 2 | OXSR1 | 3.98001522 |
| 3 | EPHB1 | 3.54870706 |
| 4 | PKN1 | 3.09242323 |
| 5 | ERN1 | 3.06985254 |
| 6 | IRAK3 | 2.95001358 |
| 7 | WNK4 | 2.93354860 |
| 8 | MAPKAPK5 | 2.84202721 |
| 9 | CDK19 | 2.56690547 |
| 10 | TRIB3 | 2.53749034 |
| 11 | PIM2 | 2.49280751 |
| 12 | LIMK1 | 2.46335817 |
| 13 | MAP3K3 | 2.35709137 |
| 14 | BCR | 2.34377122 |
| 15 | PBK | 2.31156199 |
| 16 | TAOK2 | 2.26767731 |
| 17 | EPHA2 | 2.24592687 |
| 18 | TESK2 | 2.22894345 |
| 19 | MET | 2.13900886 |
| 20 | UHMK1 | 2.00454142 |
| 21 | CSNK1G3 | 1.98251375 |
| 22 | TBK1 | 1.95632256 |
| 23 | SMG1 | 1.93642613 |
| 24 | PAK4 | 1.81303670 |
| 25 | CSNK1A1L | 1.80012804 |
| 26 | WNK1 | 1.79916031 |
| 27 | TNIK | 1.70146811 |
| 28 | CAMK2B | 1.66549441 |
| 29 | ROCK2 | 1.66333850 |
| 30 | MAP2K3 | 1.63625231 |
| 31 | ICK | 1.56349677 |
| 32 | SIK1 | 1.56035634 |
| 33 | VRK2 | 1.52132506 |
| 34 | CAMK2D | 1.48935477 |
| 35 | MUSK | 1.46175430 |
| 36 | NTRK1 | 1.41642985 |
| 37 | PRPF4B | 1.39559568 |
| 38 | CSNK1G1 | 1.38028684 |
| 39 | MAPKAPK3 | 1.36626211 |
| 40 | BCKDK | 1.35601219 |
| 41 | TAOK1 | 1.35564208 |
| 42 | CLK1 | 1.35000603 |
| 43 | CSNK1G2 | 1.34418938 |
| 44 | TYK2 | 1.34009565 |
| 45 | ARAF | 1.33536078 |
| 46 | DDR2 | 1.32333357 |
| 47 | CAMK2G | 1.31883053 |
| 48 | NEK6 | 1.27483654 |
| 49 | PHKG1 | 1.26243537 |
| 50 | PHKG2 | 1.26243537 |
| 51 | MAP3K12 | 1.19112705 |
| 52 | TGFBR2 | 1.18303782 |
| 53 | SGK494 | 1.17232256 |
| 54 | SGK223 | 1.17232256 |
| 55 | FGFR2 | 1.17061985 |
| 56 | KDR | 1.14539839 |
| 57 | ZAP70 | 1.11545867 |
| 58 | EPHB2 | 1.10965898 |
| 59 | PRKD1 | 1.02700758 |
| 60 | PRKD2 | 1.02534232 |
| 61 | DAPK3 | 1.00440245 |
| 62 | OBSCN | 0.99020745 |
| 63 | MAP2K2 | 0.97488194 |
| 64 | MST1R | 0.96049366 |
| 65 | TRPM7 | 0.95740506 |
| 66 | CDK14 | 0.94477848 |
| 67 | GRK6 | 0.92433600 |
| 68 | TTN | 0.92305118 |
| 69 | EPHA4 | 0.91865409 |
| 70 | MARK2 | 0.91705750 |
| 71 | RIPK1 | 0.91542242 |
| 72 | IKBKB | 0.89664889 |
| 73 | MAPK15 | 0.89524273 |
| 74 | PTK2 | 0.89041854 |
| 75 | DAPK1 | 0.88885096 |
| 76 | SIK3 | 0.88093832 |
| 77 | RIPK4 | 0.86692094 |
| 78 | PKN2 | 0.85152744 |
| 79 | LMTK2 | 0.84683526 |
| 80 | IRAK4 | 0.82921920 |
| 81 | PDPK1 | 0.81737797 |
| 82 | CDK15 | 0.81163228 |
| 83 | LRRK2 | 0.80093585 |
| 84 | FGR | 0.78502926 |
| 85 | MAP3K13 | 0.77927617 |
| 86 | DYRK2 | 0.77760984 |
| 87 | PRKCQ | 0.77308609 |
| 88 | CSK | 0.76890671 |
| 89 | CDC42BPA | 0.76608290 |
| 90 | SCYL2 | 0.75777017 |
| 91 | CDK11A | 0.75561376 |
| 92 | CAMK2A | 0.74396136 |
| 93 | MST4 | 0.74320850 |
| 94 | CDK18 | 0.72258015 |
| 95 | JAK3 | 0.70653164 |
| 96 | ILK | 0.69933879 |
| 97 | RPS6KA5 | 0.69313790 |
| 98 | BLK | 0.68205718 |
| 99 | MAP3K14 | 0.67581195 |
| 100 | CDK5 | 0.67195113 |
| 101 | STK16 | 0.66056703 |
| 102 | TLK1 | 0.66049806 |
| 103 | STK10 | 0.65216597 |
| 104 | PNCK | 0.61892133 |
| 105 | GRK7 | 0.60887939 |
| 106 | PAK6 | 0.60856091 |
| 107 | KSR2 | 0.59950014 |
| 108 | PDGFRA | 0.59637262 |
| 109 | IKBKE | 0.59248165 |
| 110 | MAP3K8 | 0.59023107 |
| 111 | PAK1 | 0.57291088 |
| 112 | GRK5 | 0.56157031 |
| 113 | PRKG2 | 0.54205646 |
| 114 | TYRO3 | 0.53749564 |
| 115 | ABL2 | 0.52987898 |
| 116 | AURKA | 0.51454000 |
| 117 | PAK3 | 0.51378934 |
| 118 | PRKCI | 0.51031094 |
| 119 | FYN | 0.48059553 |
| 120 | NME2 | 0.47064553 |
| 121 | PTK6 | 0.46506015 |
| 122 | BMX | 0.45166896 |
| 123 | PRKD3 | 0.44501112 |
| 124 | PDK1 | 0.44430207 |
| 125 | DMPK | 0.44251764 |
| 126 | TNK2 | 0.43531414 |
| 127 | PRKCE | 0.42848878 |
| 128 | PRKG1 | 0.42717124 |
| 129 | CSNK1A1 | 0.42516340 |
| 130 | RPS6KA2 | 0.41672779 |
| 131 | PIK3CA | 0.41122579 |
| 132 | PRKACB | 0.40371162 |
| 133 | PINK1 | 0.40366498 |
| 134 | PRKCH | 0.39224549 |
| 135 | MAPK11 | 0.38783290 |
| 136 | BUB1 | 0.38074614 |
| 137 | IRAK2 | 0.37649342 |
| 138 | MAP3K11 | 0.37275981 |
| 139 | CSF1R | 0.35428905 |
| 140 | STK4 | 0.35357022 |
| 141 | CSNK1D | 0.35075191 |
| 142 | TESK1 | 0.33841622 |
| 143 | GSK3A | 0.33669493 |
| 144 | HIPK2 | 0.33401613 |
| 145 | FLT3 | 0.33023076 |
| 146 | MAPK12 | 0.32974096 |
| 147 | MAP3K1 | 0.32396386 |
| 148 | PRKCD | 0.29976323 |
| 149 | CHUK | 0.29445079 |
| 150 | STK38 | 0.29436200 |
| 151 | PRKACA | 0.28353123 |
| 152 | MOS | 0.28197307 |
| 153 | PTK2B | 0.27578727 |
| 154 | MAP4K1 | 0.27576918 |
| 155 | BRAF | 0.27541508 |
| 156 | PAK2 | 0.25823625 |
| 157 | MAPKAPK2 | 0.25088137 |
| 158 | ROCK1 | 0.22911337 |
| 159 | MYLK | 0.22553481 |
| 160 | DYRK1B | 0.22147319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.68192824 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.67055924 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.04048941 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.79974091 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.20722609 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.18800104 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.17503682 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.90352695 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.80579597 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.80556302 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.70395439 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.66459765 |
| 13 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.50999130 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.47472151 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.17450323 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.17342666 |
| 17 | Protein export_Homo sapiens_hsa03060 | 2.12714629 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.10498671 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.09739832 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04781039 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 2.01218961 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.93784736 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.92282627 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.90191161 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75122452 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70839321 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.67768800 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.65872142 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.65671757 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.61424975 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57541946 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.56151730 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54958716 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.53633514 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.51597270 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51525631 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50088568 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.38816742 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.37779076 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.36409562 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35185331 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.34211367 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31727740 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.31587772 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29433852 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29085663 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26872722 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.25914391 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 1.25663105 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23983302 |
| 51 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23276451 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22806220 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20138981 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16464101 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14733238 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11848134 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.11682305 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09430196 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 1.05780481 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04500594 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03740455 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01143073 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00719745 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00341645 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99943647 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99563529 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99105277 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.98403851 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97615390 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.96873237 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96369336 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94767665 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94744025 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.89373953 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89272611 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89156626 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88668681 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88566463 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88161226 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87201822 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.84465910 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84354841 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83514564 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82877469 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.81084929 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81032944 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.80892903 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79638571 |
| 89 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.76371663 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75060531 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74904610 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.73630097 |
| 93 | Axon guidance_Homo sapiens_hsa04360 | 0.72614115 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71817365 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70269696 |
| 96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67799819 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.67254079 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66106828 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66092156 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.65746142 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65339294 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61227534 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.61161570 |
| 104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60703776 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59632707 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59467995 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59439674 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59408343 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59130873 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59089562 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58950768 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.58301828 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57443305 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56102153 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55124226 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53960953 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52412459 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51422690 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51312691 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50197509 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.50001861 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49808711 |
| 123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49041268 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48367099 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48025681 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46640031 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46286984 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46205810 |
| 129 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46138507 |
| 130 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45727591 |
| 131 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45412578 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45079550 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44675413 |
| 134 | Measles_Homo sapiens_hsa05162 | 0.43046310 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.42119230 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41711872 |
| 137 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40414864 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40365112 |
| 139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40235039 |
| 140 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40220117 |
| 141 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38596355 |
| 142 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38196387 |
| 143 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37396601 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36389087 |
| 145 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36019980 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35382622 |
| 147 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34264403 |
| 148 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33166491 |
| 149 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32520220 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31589907 |
| 151 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31435678 |
| 152 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31434596 |
| 153 | Morphine addiction_Homo sapiens_hsa05032 | 0.31151032 |
| 154 | Tight junction_Homo sapiens_hsa04530 | 0.30244817 |
| 155 | Malaria_Homo sapiens_hsa05144 | 0.27534620 |
| 156 | Prion diseases_Homo sapiens_hsa05020 | 0.27108553 |
| 157 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26820459 |
| 158 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25120923 |
| 159 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21643582 |
| 160 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20563828 |
| 161 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.19805841 |
| 162 | Mineral absorption_Homo sapiens_hsa04978 | 0.19772714 |
| 163 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.18408030 |
| 164 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18289869 |
| 165 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15384479 |
| 166 | Alcoholism_Homo sapiens_hsa05034 | 0.13675800 |
| 167 | Salivary secretion_Homo sapiens_hsa04970 | 0.13657330 |
| 168 | Phagosome_Homo sapiens_hsa04145 | 0.13514008 |
| 169 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.13312173 |
| 170 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.11785738 |

